Recurrent coronary disease in HIV-infected patients: role of drug–drug interactions

Iria Bravo, Hortensia Álvarez, Ana Mariño, Bonaventura Clotet, José Moltó

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)


© 2018 The British Pharmacological Society Cardiovascular disease represents a leading comorbidity in HIV populations. Different factors may contribute to the recurrence of cardiovascular events in HIV-infected patients. Here, we describe two patients with HIV infection and an acute coronary syndrome who developed in-stent thrombosis after a percutaneous revascularization procedure. Also, we discuss the potential role of drug interactions between antiretroviral and antiplatelet treatments as a contributing factor for recurrent coronary disease in HIV-infected patients.
Original languageEnglish
Pages (from-to)1617-1619
JournalBritish Journal of Clinical Pharmacology
Issue number7
Publication statusPublished - 1 Jul 2018


  • HIV infection
  • coronary disease
  • drug interactions


Dive into the research topics of 'Recurrent coronary disease in HIV-infected patients: role of drug–drug interactions'. Together they form a unique fingerprint.

Cite this